Vbi Vaccines Stock Today
| VBIV Stock | USD 0.63 0.02 3.28% |
Performance2 of 100
| Odds Of DistressOver 83
|
VBI Vaccines is selling for under 0.63 as of the 18th of April 2024; that is 3.28 percent increase since the beginning of the trading day. The stock's lowest day price was 0.58. VBI Vaccines has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for VBI Vaccines are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of September 2022 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 18th of August 1995 | Category Healthcare | Classification Health Care |
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts. Vbi Vaccines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 28.43 M outstanding shares of which 289.12 K shares are at this time shorted by private and institutional investors with about 3.78 trading days to cover. More on VBI Vaccines
Moving against VBI Stock
| 0.53 | GRTX | Galera Therapeutics Financial Report 9th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 20th of May 2024
VBI Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. VBI Vaccines' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding VBI Vaccines or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Director | Curtis Lockshin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Pharmaceutical Products (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Pharmaceutical Products, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering VBI Vaccines report their recommendations after researching VBI Vaccines' financial statements, talking to executives and customers, or listening in on VBI Vaccines' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering VBI Vaccines. The VBI consensus assessment is calculated by taking the average forecast from all of the analysts covering VBI Vaccines. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to VBI Vaccines' liquidity, profitability, solvency, and operating efficiency, VBI Vaccines is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of VBI Vaccines is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VBI Vaccines' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to VBI Vaccines' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand VBI Vaccines' financial leverage. It provides some insight into what part of VBI Vaccines' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VBI Vaccines (VBIV) is traded on NASDAQ Exchange in USA. It is located in 160 Second Street, Cambridge, MA, United States, 02142 and employs 190 people. VBI Vaccines is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.63 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate VBI Vaccines's market, we take the total number of its shares issued and multiply it by VBI Vaccines's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. VBI Vaccines conducts business under Biotechnology sector and is part of Health Care industry. The entity has 28.43 M outstanding shares of which 289.12 K shares are at this time shorted by private and institutional investors with about 3.78 trading days to cover.
VBI Vaccines currently holds about 82.41 M in cash with (60.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32.
Check VBI Vaccines Probability Of Bankruptcy
Ownership AllocationVBI Vaccines maintains a total of 28.43 Million outstanding shares. VBI Vaccines has 7.69 % of its outstanding shares held by insiders and 11.84 % owned by institutional holders. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check VBI Ownership Details
VBI Stock Price Odds Analysis
Depending on a normal probability distribution, the odds of VBI Vaccines jumping above the current price in 90 days from now is about 43.29%. The VBI Vaccines probability density function shows the probability of VBI Vaccines stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days VBI Vaccines has a beta of 0.4931. This entails as returns on the market go up, VBI Vaccines average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding VBI Vaccines will be expected to be much smaller as well. Additionally, vBI Vaccines has an alpha of 0.189, implying that it can generate a 0.19 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of VBI Vaccines to move above the current price in 90 days from now is about 43.29 (This VBI Vaccines probability density function shows the probability of VBI Stock to fall within a particular range of prices over 90 days) .
VBI Stock Institutional Holders
Institutional Holdings refers to the ownership stake in VBI Vaccines that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of VBI Vaccines' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing VBI Vaccines' value.| Instituion | Recorded On | Shares | |
| Alpine Partners Vi, Llc | 2023-12-31 | 25 K | |
| Two Sigma Securities, Llc | 2023-12-31 | 24.6 K | |
| Millennium Management Llc | 2023-12-31 | 22 K | |
| Warberg Asset Management Llc | 2023-12-31 | 15 K | |
| Captrust Financial Advisors | 2023-12-31 | 12.3 K | |
| Steward Partners Investment Advisory, Llc | 2023-12-31 | 3.1 K | |
| Royal Bank Of Canada | 2023-12-31 | 1.4 K | |
| Newbridge Financial Services Group, Inc. | 2023-12-31 | 1.2 K | |
| Wetzel Investment Advisors Inc | 2023-12-31 | 1000 | |
| Perceptive Advisors Llc | 2023-12-31 | 1.4 M | |
| Alyeska Investment Group, L.p. | 2023-09-30 | 696.7 K |
VBI Vaccines Historical Income Statement
VBI Vaccines Income Statement is one of the three primary financial statements used for reporting VBI's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of VBI Vaccines revenue and expense. VBI Vaccines Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, VBI Vaccines' Selling General Administrative is fairly stable compared to the past year. Total Revenue is likely to climb to about 9.1 M in 2024, whereas Gross Profit is likely to drop (4 M) in 2024. View More FundamentalsVBI Stock Against Markets
Picking the right benchmark for VBI Vaccines stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in VBI Vaccines stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for VBI Vaccines is critical whether you are bullish or bearish towards VBI Vaccines at a given time. Please also check how VBI Vaccines' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in VBI Vaccines without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
| All Next | Launch Module |
VBI Vaccines Corporate Directors
VBI Vaccines corporate directors refer to members of a VBI Vaccines board of directors. The board of directors generally takes responsibility for the VBI Vaccines' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of VBI Vaccines' board members must vote for the resolution. The VBI Vaccines board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Trent Davis | Director | Profile | |
| Joanne Cordeiro | Director | Profile | |
| Sam Chawla | Director | Profile | |
| Alan Timmins | Independent Director | Profile |
How to buy VBI Stock?
Before investing in VBI Vaccines, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in VBI Vaccines. To buy VBI Vaccines stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of VBI Vaccines. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase VBI Vaccines stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located VBI Vaccines stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased VBI Vaccines stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as VBI Vaccines, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.
Already Invested in VBI Vaccines?
The danger of trading VBI Vaccines is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of VBI Vaccines is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than VBI Vaccines. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile VBI Vaccines is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether VBI Vaccines is a strong investment it is important to analyze VBI Vaccines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact VBI Vaccines' future performance. For an informed investment choice regarding VBI Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for VBI Stock analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.79) | Revenue Per Share 0.689 | Quarterly Revenue Growth 19.896 | Return On Assets (0.29) | Return On Equity (2.20) |
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.